012 - Taking Medicines Back to The Future – A Discussion with Hedley Rees on Value Chain vs. Supply Chain: What's the Difference?

What We Covered00:59 – Hedley Rees joins the show to share his background in the pharmaceutical industry, his thoughts on Big Pharma and issues he’s observed with medicine coming to market09:43 – Hedley speaks to the importance of designing supply chains strategically and why your supply chain is actually your value chain17:51 – Hedley discusses outsourcing in the pharmaceutical industry24:07 – Hedley provides his thoughts on Quality by Design (QBD), including changes that must be made to the process39:22 – Hedley shares some of his upcoming projects42:27 – Ed, Brian and Meranda thank Hedley for joining the showTweetable Quotes

“If they all beat together at the same time, instead of taking sixteen years for penicillin to come to market it would take maybe four years.” 

“The main point between strategic supply team management is you actually engage with the end user of your product the same way as Apple would or any company who really builds value into their products.” 

“The value that you add – the money you bring in – has got to be less than the cost that you incur in the business and then you obviously make a profit grow.” 

“In terms of procurement, the industry has outsourced this critical asset.” 

“The problem with pharma is that there is no competition because once you’ve got a patented molecule approved, the most that’s gonna happen is you get an oligopoly where two or three companies make blockbuster revenue.” 

“The body is the most complex, connected thing in the world.” 

“The other thing that people have noticed is that you can develop a drug now without being a pharma company.” 

Design Space InPharmatics - LinkedIn

Design Space InPharmatics - Twitter

Edward Narke on LinkedIn

Hedley Rees on LinkedIn

Hedley’s Book – Taming the Big Pharma Monster By Speaking Truth to Power

Hedley’s Blog PharmaFlow

Cutting Through the QBD Foliage, Aiming for the Roots Article